Mariza Fevereiro-Martins

Dr. Mariza Fevereiro-Martins

Genetics Laboratory, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Lisboa, Portugal
+2
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2022 in Survey of Ophthalmology
Verified
Journal Article
Open access
Mariza Fevereiro-MartinsMariza Fevereiro-Martins
Mariza Fevereiro-Martins
CMCarlos Marques-Neves
Carlos Marques-Neves
HGHercília Guimarães
Hercília Guimarães
Manuel BichoManuel Bicho
Manuel Bicho
Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the retina and a leading cause of visual impairment and childhood blindness worldwide. The disease is characterized by an early stage of retinal microvascular degeneration, followed by neovascularization that can lead to subsequent retinal detachment and permanent visual loss. Several factors play a key role during the different pathological stages of the disease. Oxidative and nitrosative stress and inflammatory processes are important contributors to the early stage of ROP. Nitric oxide synthase and arginase play important roles in ischemia/reperfusion-induced neurovascular degeneration. Destructive neovascularization is driven by mediators of the hypoxia-inducible factor pathway, such as vascular endothelial growth factor and metabolic factors (succinate). The extracellular matrix is involved in hypoxia-induced retinal neovascularization. Vasorepulsive molecules (semaphorin 3A) intervene preventing the revascularization of the avascular zone. This review focuses on current concepts about signaling pathways and their mediators, involved in the pathogenesis of ROP, highlighting new potentially preventive and therapeutic modalities. A better understanding of the intricate molecular mechanisms underlying the pathogenesis of ROP should allow the development of more effective and targeted therapeutic agents to reduce aberrant vasoproliferation and facilitate physiological retinal vascular development.

9 March 2022 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
Mariza Fevereiro-MartinsMariza Fevereiro-Martins
Mariza Fevereiro-Martins
MAMARIA HERCILIA FEREIRA GUIMARAES AREIAS
MARIA HERCILIA FEREIRA GUIMARAES AREIAS
CMCarlos Marques-Neves
Carlos Marques-Neves
Manuel BichoManuel Bicho
Manuel Bicho

2 May 2023 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Open access
PDF file
Mariza Fevereiro-MartinsMariza Fevereiro-Martins
Mariza Fevereiro-Martins
ASAna Carolina Santos
Ana Carolina Santos
CMCarlos Marques-Neves
Carlos Marques-Neves
MAMARIA HERCILIA FEREIRA GUIMARAES AREIAS
MARIA HERCILIA FEREIRA GUIMARAES AREIAS
Manuel BichoManuel Bicho
Manuel Bicho
Purpose: To evaluate complete blood count (CBC) parameters in the first week of life as predictive biomarkers for the development of retinopathy of prematurity (ROP). Methods: Multicenter, prospective, observational study of a cohort of preterm infants born with gestational age (GA) < 32 weeks or birth weight < 1500 g in eight Portuguese neonatal intensive care units. All demographic, clinical, and laboratory data from the first week of life were collected. Univariate logistic regression was used to assess risk factors for ROP and then multivariate regression was performed. Results: A total of 455 infants were included in the study. The median GA was 29.6 weeks, and the median birth weight was 1295 g. One hundred and seventy-two infants (37.8%) developed ROP. Median values of erythrocytes (p < 0.001), hemoglobin (p < 0.001), hematocrit (p < 0.001), mean corpuscular hemoglobin concentration (p < 0.001), lymphocytes (p = 0.035), and platelets (p = 0.003) of the group of infants diagnosed with ROP any stage were lower than those without ROP. Mean corpuscular volume (MCV) (p = 0.044), red blood cell distribution width (RDW) (p < 0.001), erythroblasts (p < 0.001), neutrophils (p = 0.030), neutrophils-lymphocytes ratio (p = 0.028), and basophils (p = 0.003) were higher in the ROP group. Higher values of MCV, erythroblasts, and basophils remained significantly associated with ROP after multivariate regression. Conclusion: In our cohort, the increase in erythroblasts, MCV, and basophils in the first week of life was significantly and independently associated with the development of ROP. These CBC parameters may be early predictive biomarkers for ROP.

6 January 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
Mariza Fevereiro-MartinsMariza Fevereiro-Martins
Mariza Fevereiro-Martins
LALaura de Investigação Científica Bento da Rocha Aguiar
Laura de Investigação Científica Bento da Rocha Aguiar
Angela Ribeiro Marques InácioAngela Ribeiro Marques Inácio
Angela Ribeiro Marques Inácio
ACAntónio Carlos da Silva Cardoso
António Carlos da Silva Cardoso
ASAna Carolina Santos
Ana Carolina Santos
Manuel BichoManuel Bicho
Manuel Bicho
Background/Objectives: Retinopathy of prematurity (ROP) is a leading cause of vision impairment in preterm infants, with its pathogenesis linked to oxygen exposure. Red blood cell (RBC) transfusions, commonly performed in neonatal intensive care units (NICUs), reduce fetal hemoglobin (HbF) fraction, altering oxygen dynamics and potentially contributing to ROP. We aimed to investigate the relationship between RBC transfusions, HbF percentage, and ROP, evaluating HbF as a potential predictive biomarker. Methods: A multicenter, prospective study was conducted across eight Portuguese NICUs, involving infants born at <32 weeks gestational age (GA) or <1500 g. ROP staging followed the International Classification of ROP (ICROP2). Clinical data were collected during hospitalization, and HbF fractions were measured from blood samples in the first four weeks of life using standardized methods. Infants were stratified by ROP presence and treatment requirement. Statistical analysis was performed using SPSS 28.0, with p < 0.05. Results: Eighty-two infants (mean GA: 28.1 ± 2.1 weeks, birth weight: 1055.8 ± 258.3 g) were included. Among them, 29 (35.4%) presented ROP and 4 (4.9%) required treatment. Infants with ROP had more RBC transfusions and lower HbF percentages than those without ROP (p < 0.05). Lower HbF was associated with more RBC transfusions (p < 0.001). Kaplan–Meier survival curves showed a higher ROP risk in infants with reduced HbF (p < 0.05). Conclusions: Low HbF percentage in the first four weeks of life may increase ROP risk in preterm infants. HbF could serve as a biomarker for ROP prediction. Interventions preserving HbF may reduce ROP risk. Further studies are needed to validate HbF as a biomarker and refine prevention strategies.

Verified
Journal Article
Open access
PDF file
Mariza Fevereiro-MartinsMariza Fevereiro-Martins
Mariza Fevereiro-Martins
ASAna Carolina Santos
Ana Carolina Santos
CMCarlos Marques-Neves
Carlos Marques-Neves
MAMARIA HERCILIA FEREIRA GUIMARAES AREIAS
MARIA HERCILIA FEREIRA GUIMARAES AREIAS
Manuel BichoManuel Bicho
Manuel Bicho
OGon behalf of the GenE-ROP Study Group
on behalf of the GenE-ROP Study Group
The development of retinopathy of prematurity (ROP) may be influenced by anemia or a low fetal/adult hemoglobin ratio. We aimed to analyze the association between DNA methyltransferase 3 β (DNMT3B) (rs2424913), methylenetetrahydrofolate reductase (MTHFR) (rs1801133), and lysine-specific histone demethylase 1A (KDM1A) (rs7548692) polymorphisms, erythrocyte parameters during the first week of life, and ROP. In total, 396 infants (gestational age < 32 weeks or birth weight < 1500 g) were evaluated clinically and hematologically. Genotyping was performed using a MicroChip DNA on a platform employing iPlex MassARRAY®. Multivariate regression was performed after determining risk factors for ROP using univariate regression. In the group of infants who developed ROP red blood cell distribution width (RDW), erythroblasts, and mean corpuscular volume (MCV) were higher, while mean hemoglobin and mean corpuscular hemoglobin concentration (MCHC) were lower; higher RDW was associated with KDM1A (AA), MTHFR (CC and CC + TT), KDM1A (AA) + MTHFR (CC), and KDM1A (AA) + DNMT3B (allele C); KDM1A (AA) + MTHFR (CC) were associated with higher RDW, erythroblasts, MCV, and mean corpuscular hemoglobin (MCH); higher MCV and MCH were also associated with KDM1A (AA) + MTHFR (CC) + DNMT3B (allele C). We concluded that the polymorphisms studied may influence susceptibility to ROP by modulating erythropoiesis and gene expression of the fetal/adult hemoglobin ratio.

24 September 2024 in Children
Verified
Journal Article
Open access
PDF file
Mariza Fevereiro-MartinsMariza Fevereiro-Martins
Mariza Fevereiro-Martins
ASAna Carolina Santos
Ana Carolina Santos
CMCarlos Marques-Neves
Carlos Marques-Neves
Manuel BichoManuel Bicho
Manuel Bicho
MAMARIA HERCILIA FEREIRA GUIMARAES AREIAS
MARIA HERCILIA FEREIRA GUIMARAES AREIAS
OGon behalf of the GenE-ROP Study Group
on behalf of the GenE-ROP Study Group
Background/Objectives: Retinopathy of prematurity (ROP) is a retinal neovascular disease affecting preterm infants. Identifying risk factors for its development and progression is critical for effective screening and prevention. This study aimed to analyze the incidence of ROP and identify key risk factors for its development and progression. Methods: We conducted a prospective, observational cohort study on 455 neonates (gestational age [GA] < 32 weeks or birth weight < 1500 g) across eight Portuguese NICUs. Results: ROP incidence was 37.8%, with 4.6% requiring treatment. Multivariate analysis identified low GA and the number of red blood cell (RBC) transfusions as significant factors for ROP development and progression. After adjusting for these variables, platelet transfusions, high maximum fraction of inspired oxygen (FiO2) in the second week, and surfactant use remained significantly associated with ROP development, while early and late sepsis, maternal chronic hypertension, and delayed enteral nutrition were associated with progression to ROP requiring treatment. Conclusions: These findings underscore the importance of addressing low GAs and adult RBC transfusions in ROP risk management and suggest that maximum FiO2, platelet transfusions, and sepsis also play crucial roles. Larger studies are needed to validate these results and explore preventive interventions, particularly regarding the impact of multiple adult RBC transfusions on fetal hemoglobin percentages.